Véronique Verrièle
Institut de Cancérologie de l'Ouest(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Ovarian cancer diagnosis and treatment, Intraperitoneal and Appendiceal Malignancies
Most-Cited Works
- → Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response(2015)329 cited
- → Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer(2009)238 cited
- → Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial(2019)193 cited
- → Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications(2019)116 cited
- → Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database(2016)89 cited
- → Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort(2021)85 cited
- → Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment(2019)84 cited
- → Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples(2015)53 cited
- → Mise à jour 2014 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers du sein en France(2014)50 cited
- → Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en France(2021)43 cited